Calmodulin kinase II is required for angiotensin II-mediated vascular smooth muscle hypertrophy.
about
Dysregulation of histone acetyltransferases and deacetylases in cardiovascular diseasesMechanisms of Vascular Smooth Muscle Contraction and the Basis for Pharmacologic Treatment of Smooth Muscle DisordersCa2+/calmodulin-dependent protein kinase II function in vascular remodellingMEF2 is regulated by CaMKIIδ2 and a HDAC4-HDAC5 heterodimer in vascular smooth muscle cellsHDAC4 mediates development of hypertension via vascular inflammation in spontaneous hypertensive rats.Molecular Signals Elicited by GPCR Agonists in Hypertension, Cardiovascular Remodeling: Are MMPs and ADAMs Elusive Therapeutic Targets?Eukaryotic elongation factor 2 kinase regulates the development of hypertension through oxidative stress-dependent vascular inflammationCalmodulin promotes matrix metalloproteinase 9 production and cell migration by inhibiting the ubiquitination and degradation of TBC1D3 oncoprotein in human breast cancer cells.Calcium/calmodulin-dependent kinase II mediates the phosphorylation and activation of NADPH oxidase 5.Distinct effects of voltage- and store-dependent calcium influx on stretch-induced differentiation and growth in vascular smooth muscle.The multifunctional Ca2+/calmodulin-dependent kinase II delta (CaMKIIdelta) controls neointima formation after carotid ligation and vascular smooth muscle cell proliferation through cell cycle regulation by p21.The multifunctional Ca²⁺/calmodulin-dependent kinase IIδ (CaMKIIδ) regulates arteriogenesis in a mouse model of flow-mediated remodeling.CaMKII is essential for the proasthmatic effects of oxidation.Cell excitability necessary for male mating behavior in Caenorhabditis elegans is coordinated by interactions between big current and ether-a-go-go family K(+) channels.Oxidation of CaMKII determines the cardiotoxic effects of aldosterone.The multifunctional Ca2+/calmodulin-dependent kinase II regulates vascular smooth muscle migration through matrix metalloproteinase 9.Calcium/calmodulin-dependent kinase II inhibition in smooth muscle reduces angiotensin II-induced hypertension by controlling aortic remodeling and baroreceptor function.Nuclear Calcium/Calmodulin-dependent Protein Kinase II Signaling Enhances Cardiac Progenitor Cell Survival and Cardiac Lineage CommitmentCaMKII inhibition in type II pneumocytes protects from bleomycin-induced pulmonary fibrosis by preventing Ca2+-dependent apoptosis.Ca2+/calmodulin-dependent protein kinase II-γ (CaMKIIγ) negatively regulates vascular smooth muscle cell proliferation and vascular remodelingOxidant stress promotes disease by activating CaMKII.Oxidative activation of the Ca(2+)/calmodulin-dependent protein kinase II (CaMKII) regulates vascular smooth muscle migration and apoptosis.CaMKII in the cardiovascular system: sensing redox states.Epigenetic regulation of vascular smooth muscle cell function in atherosclerosis.Oxidative stress-mediated effects of angiotensin II in the cardiovascular systemVascular CaMKII: heart and brain in your arteries.STIM-1 and ORAI-1 channel mediate angiotensin-II-induced expression of Egr-1 in vascular smooth muscle cells.Overexpression of microRNA-145 in atherosclerotic plaques from hypertensive patients.Association of genetic variation in calmodulin and left ventricular mass in full-term newborns.The main target for inhibiting mineralocorticoid receptor-mediated signaling in cardiovascular diseases.Role of CaMKII in Ang-II-dependent small artery remodeling.Gallic Acid Reduces Blood Pressure and Attenuates Oxidative Stress and Cardiac Hypertrophy in Spontaneously Hypertensive Rats.Endothelial CaMKII as a regulator of eNOS activity and NO-mediated vasoreactivity.Gallic acid attenuates calcium calmodulin-dependent kinase II-induced apoptosis in spontaneously hypertensive rats.The mechanism and potential targets of class II HDACs in angiogenesis.
P2860
Q21284678-EA25C88E-FD88-420C-959A-47E1C2EC3F17Q26753129-507D3917-D477-4797-80A1-F4ED92ECC8D2Q26830342-DE20E2A5-9879-421A-A04B-6AE8BDE03820Q28576431-73BED2D4-309B-4AED-B819-E19B8A0D384CQ29347006-A0A89BA0-51D6-4570-9FF8-2F96AC718B46Q33807091-BD6F5689-7142-4AC2-A508-228FD490AC76Q33816742-1FBEEE17-209B-4A10-832C-B463470865F9Q33829502-E9EB30AE-D5AF-4768-95A4-047D7C8941B8Q33923188-0CC3141B-1EA0-4700-A1C9-78E19E963F4DQ34181603-A61423F2-90DA-4CEB-828E-939F0AF31CABQ34624215-46EF6CB9-5402-4A70-AC81-5D459795BB3AQ34949842-343D2087-2644-4E9E-B6EE-DE5AEA4CC62BQ35091137-D2EDE6B2-538B-45AB-8384-7A3FED1FEA92Q35810755-4A631D2B-1109-4D26-93D0-102A13FFFD59Q35903753-F010E106-9FC4-4DFE-9D61-903709CF8026Q35994104-B6E80543-778F-4E77-AFFD-309D9D13352FQ36141985-D977B712-3136-469E-A4F7-EBEBD9BE0593Q36283312-F2B211AF-B8F5-4BCC-AB46-3E5ECA1F410EQ36422643-2FE29676-488C-47A4-AF46-31ED3185A418Q36570927-935F92C1-C311-413C-A36D-9D3C0273254EQ37358999-F0199873-88AA-48A5-96BF-CB1569E798AAQ37638723-32916B7F-B578-42D7-A068-4AD9A9ECD411Q37899670-39F8F4E2-880D-40C7-8177-F14D761994A4Q38083011-E8A0CD6D-DBE5-4531-A2ED-0E8654016DB3Q38192646-8F979CBE-88DB-449E-AE51-A86D4EB37061Q38866040-80CFC24D-C85F-4D0B-BE86-5E0124001583Q39010799-415146DF-E196-4B06-A7B9-46EDF06C8673Q39481193-78BAA71B-9C7D-404F-9251-165817C09160Q41788990-0F0660DA-BCE4-4639-850D-73F85A3D64B6Q43937702-EB5CDFBC-7EA1-467A-BA50-ABF6661A7672Q46706168-49B6DEA0-962D-412F-8F2D-D419E5DF72C2Q47116161-A56B93DA-88DB-4E54-AF51-96772D433DE4Q47148927-8D0675BA-5036-4C34-AC38-518DD7DB86E8Q47265828-00921ED4-06A4-44C4-8964-2DD489FEE3D1Q47865822-29298D2A-E64F-43AC-A999-A9AC74D544A1
P2860
Calmodulin kinase II is required for angiotensin II-mediated vascular smooth muscle hypertrophy.
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Calmodulin kinase II is requir ...... lar smooth muscle hypertrophy.
@ast
Calmodulin kinase II is requir ...... lar smooth muscle hypertrophy.
@en
type
label
Calmodulin kinase II is requir ...... lar smooth muscle hypertrophy.
@ast
Calmodulin kinase II is requir ...... lar smooth muscle hypertrophy.
@en
prefLabel
Calmodulin kinase II is requir ...... lar smooth muscle hypertrophy.
@ast
Calmodulin kinase II is requir ...... lar smooth muscle hypertrophy.
@en
P2093
P2860
P1476
Calmodulin kinase II is requir ...... ular smooth muscle hypertrophy
@en
P2093
Arun K Gupta
Mark E Anderson
Peter J Mohler
P2860
P304
P356
10.1152/AJPHEART.01014.2009
P577
2009-12-18T00:00:00Z